Related Experiment Video
Updated: Aug 6, 2025

Using Zebrafish Models of Human Influenza A Virus Infections to Screen Antiviral Drugs and Characterize Host Immune Cell Responses
Published on: January 20, 2017
Gasdermin D promotes influenza virus-induced mortality through neutrophil amplification of inflammation
Samuel Speaks1, Ashley Zani1,2, Abigail Solstad1
1Department of Microbial Infection and Immunity, The Ohio State University, Columbus, OH 43210.
Abstract:
Influenza virus activates cellular inflammasome pathways, which can be either beneficial or detrimental to infection outcomes. Here, we investigated the role of the inflammasome-activated pore-forming protein gasdermin D (GSDMD) during infection. Ablation of GSDMD in knockout (KO) mice significantly attenuated virus-induced weight loss, lung dysfunction, lung histopathology, and mortality compared with wild type (WT) mice, despite similar viral loads. Infected GSDMD KO mice exhibited decreased inflammatory gene signatures revealed by lung transcriptomics, which also implicated a diminished neutrophil response. Importantly, neutrophil depletion in infected WT mice recapitulated the reduced mortality and lung inflammation observed in GSDMD KO animals, while having no additional protective effects in GSDMD KOs. These findings reveal a new function for GSDMD in promoting lung neutrophil responses that amplify influenza virus-induced inflammation and pathogenesis. Targeting the GSDMD/neutrophil axis may provide a new therapeutic avenue for treating severe influenza.
Insights
Gasdermin D (GSDMD) amplifies lung inflammation and severity during influenza virus infection by promoting neutrophil responses. Targeting GSDMD may offer new treatments for severe flu.
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- Influenza virus infection triggers inflammasome pathways, impacting disease severity.
- Gasdermin D (GSDMD) is a key protein activated by inflammasomes, forming pores in cell membranes.
Approach:
- Investigated GSDMD's role in influenza using GSDMD knockout (KO) mice and wild-type (WT) mice.
- Analyzed lung histopathology, viral loads, gene expression (transcriptomics), and neutrophil responses.
- Utilized neutrophil depletion experiments in WT mice to confirm GSDMD's mechanism.
Key Points:
- GSDMD deficiency in mice significantly reduced influenza-induced weight loss, lung damage, and mortality.
- Transcriptomics revealed decreased inflammatory gene signatures and neutrophil infiltration in GSDMD KO mice.
- Neutrophil depletion mimicked GSDMD KO protection in WT mice, highlighting neutrophils as critical mediators.
Conclusions:
- GSDMD promotes lung neutrophil recruitment and activation, exacerbating influenza pathogenesis.
- The GSDMD-neutrophil axis represents a novel therapeutic target for severe influenza infections.
Related Concept Videos
Leaky Scanning
Inflammation

